SR ONE CAPITAL MANAGEMENT, LLC
SEC insider (Form 3/4/5 filer). CIK 0001853723. 10% Owner at ADARx Pharmaceuticals, Inc. (ADRX) and 3 other issuers. 44 reported Form 4/5 transactions since Sep 2024; latest on Sep 28, 2026. Located in REDWOOD CITY, CA.
Companies SR ONE CAPITAL MANAGEMENT, LLC has filed insider reports for
- ADARx Pharmaceuticals, Inc. (ADRX): 10% Owner
- Odyssey Therapeutics, Inc. (ODTX): 10% Owner
- Avalyn Pharma Inc. (AVLN): 10% Owner
- Zenas BioPharma, Inc. (ZBIO): 10% Owner
SR ONE CAPITAL MANAGEMENT, LLC
CIK: 0001853723
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (44 total)
- Sep 28, 2026ADRX
ADARx Pharmaceuticals, Inc.
PurchaseIndirect414.8K shares at avg. $17.00$7.1M - Sep 28, 2026ADRX
ADARx Pharmaceuticals, Inc.
PurchaseIndirect592.6K shares at avg. $17.00$10.1M - Sep 28, 2026ADRX
ADARx Pharmaceuticals, Inc.
ConversionIndirect512.9K shares- - Sep 28, 2026ADRX
ADARx Pharmaceuticals, Inc.
ConversionIndirect1.5M shares- - Sep 28, 2026ADRX
ADARx Pharmaceuticals, Inc.
ConversionIndirect1.7M shares- - Sep 28, 2026ADRX
ADARx Pharmaceuticals, Inc.
ConversionIndirect169K shares- - Sep 28, 2026ADRX
ADARx Pharmaceuticals, Inc.
ConversionIndirect3.3M shares- - Sep 28, 2026ADRX
ADARx Pharmaceuticals, Inc.
ConversionIndirect1.1M shares- - Sep 28, 2026ADRX
ADARx Pharmaceuticals, Inc.
PurchaseIndirect592.6K shares at avg. $17.00$10.1M - May 11, 2026ODTX
Odyssey Therapeutics, Inc.
PurchaseIndirect222.2K shares at avg. $18.00$4.0M
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 28, 2026 |  ADRX ADARx Pharmaceuticals, Inc. | Purchase | 414,814 | $17.00 | $7,051,838 | Indirect |
| Sep 28, 2026 | ADRX ADARx Pharmaceuticals, Inc. | Purchase | 592,593 | $17.00 | $10,074,081 | Indirect |
| Sep 28, 2026 | ADRX ADARx Pharmaceuticals, Inc. | Conversion | 512,897 | - | $0 | Indirect |
| Sep 28, 2026 | ADRX ADARx Pharmaceuticals, Inc. | Conversion | 1,538,691 | - | $0 | Indirect |
| Sep 28, 2026 | ADRX ADARx Pharmaceuticals, Inc. | Conversion | 1,667,468 | - | $0 | Indirect |
| Sep 28, 2026 | ADRX ADARx Pharmaceuticals, Inc. | Conversion | 169,001 | - | $0 | Indirect |
| Sep 28, 2026 | ADRX ADARx Pharmaceuticals, Inc. | Conversion | 3,334,938 | - | $0 | Indirect |
| Sep 28, 2026 | ADRX ADARx Pharmaceuticals, Inc. | Conversion | 1,113,666 | - | $0 | Indirect |
| Sep 28, 2026 | ADRX ADARx Pharmaceuticals, Inc. | Purchase | 592,593 | $17.00 | $10,074,081 | Indirect |
| May 11, 2026 |  ODTX Odyssey Therapeutics, Inc. | Purchase | 222,222 | $18.00 | $3,999,996 | Indirect |
1-10 of 44 transactions